Professional Associations that bring together competing entities, such as HL7, are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 activities, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Getting issue details...STATUS
was previously approved by the WG on Nov. 10th
Project is open-ended at this point – could include infrastructural recommendations and / or IG artifacts
Steve Eichner recommended specifying that any published artifacts should be clear that they are just technical documentation and that there are policy considerations about who can actually access immunization data in bulk
WG approved PSS / primary sponsorship 26-0-0 (motion: Danny, second: John Stamm)
Craig introduced a "how-to" / primer document for new WG participants about HL7 in general, the Public Health Work Group, Helios and other FHIR Accelerators, how to participate, etc.
Will review further in future calls
A draft copy is available for comment (but keep in mind it is still draft and shouldn't be widely circulated at this point)